Diligence memo · auto-generated · as of July 2, 2026
BioScrip, Inc.
BioScrip, Inc. looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
BioScrip, Inc. operates in Other Health Care, based in ELMSFORD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
BioScrip, Inc. has raised $172M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $110M on 2010-03-25.
Most recent recorded round closed around 2015-03-09.
Valuation (modeled)modeled
Provath models BioScrip, Inc. at approximately $1.4B (range $335M–$3.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.55× the median modeled value of Series D+ Other Health Care companies in 2013–2015 (16 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 59 months.
Last raise 11.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.7× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 98% of Other Health Care peers (5377 compared).
Modeled value ranks above 98% of those peers.
Closest niche peers: Onex TSG Holdings Corp., BVO Holdings, LLC, Mdp Hc Holdings, Llc, Amsurg Corp, Greatbatch, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.